Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sartorius Stedim Biotech (SSB) is a leading international provider of equipment and services for the biopharmaceutical industry, specializing in the development and manufacture of biopharmaceuticals. The company offers a comprehensive portfolio of bioprocessing solutions, including single-use technologies, filtration, fermentation, and cell culture systems. As a key subsidiary of the Sartorius Group, SSB supports the entire biopharmaceutical value chain, from early-stage research and process development to large-scale commercial manufacturing. Its products are essential for the production of complex medications such as monoclonal antibodies, vaccines, and cell and gene therapies. Headquartered in Aubagne, France, SSB is a publicly traded entity and a critical pillar of the global life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SSB Solutions.